Long-term survivors in myelodysplastic syndromes: Clinical and biological characteristics

Medical Oncology

Volumn 21, Issue 4, 2004, Pages 333-338

  Marisavljević, Dragomir ^a   Rolović, Zoran ^a   Bošković, Darinka ^a   Čolović, Milica ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Long term survivors; Myelodysplastic syndrome; Prognosis; Risk classification

Indexed keywords

ANDROGEN; CYTARABINE; DANAZOL; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; KARYOTYPE; LOW DRUG DOSE; MALE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; SCORING SYSTEM; SURVIVAL RATE; TECHNIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVORS;

EID: 11244270292     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:21:4:333     Document Type: Article

References (21)

1. Bennett J, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-199.
2. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59:425-433.
3. Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen L. Bone marrow histology in the myelodysplastic syndromes. II. Prognostic value of abnormal localization of precursors in MDS. Br J Haematol 1984; 58:217-225.
4. Sanz G, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivanate analysis of prognostic factors in 370 patients. Blood 1989; 74:395-408.
5. Aul C, et al. Primary myelodysplastic syndromes (MDS): analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6:52-59.
6. Morel P, et al. Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7:1315-1323.
7. Greenberg P, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:2079-2088.
8. Mangi M, Mufti G. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992; 79:198-205.
9. Maschek H, Gutzmer R, Choritz H, Georgii A. Life expectancy in primary myelodysplastic syndromes (pMDS): A prognostic score based upon histopathology from bone marrow biopsies of 569 patients. Eur J Haematol 1994; 53:280-287.
10. Goasguen J, et al. Prognostic factors of myelodysplastic syndromes - a simplified 3-D scoring system. Leuk Res 1990; 14:255-262.
11. Raymakers R, Preijers F, Boezeman J, Rutten E, De Witte T. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis. Leuk Lymphoma 1993; 14:111-120.
12. Worsley A, et al. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 1988; 68:17-21.
13. Boogaerts M, Verhoef G, Demuynck H. Treatment and prognostic factors in myelodysplastic syndromes. Bailliere,s Clinical Haematology 1996; 9(1):161-183.
14. Yoshida Y, Oguma S, Uchino H, Maekawa T, Nomura T. Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study. Leuk Res 1992; 8:775-779.
15. Wattel E, et al. Long term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors. Leuk Res 1993; 17(9):733-739.
16. Reizenstein P, Ost A. Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. Leuk Res 1992; 16(1):3-11.
17. Novak A, Kruškić M, Ludoški M, Jurkovski V. Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia. Cancer Genet Cytogenet 1994; 74(6): 109-114.
18. ISCN. In: Felix Mitelman (ed.). An International System for Human Genetic Nomenclature. Karger: Basel, 1995.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457.
20. Marisavljević D, et al. Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes. Med Oncol 2002; 19(4):249-259.
21. Marisavljević D, Bošković D. Spontaneous remission in myelodysplastic syndromes: incidence and patient,s characteristics. Fifth International Symposium on Myelodysplastic Syndromes. Prague, Czech Republic, 21-24 April 1999. Leuk Res 1999; 23(suppl 1):Abs. No. 82.